A new study by investigators from Mass General Brigham suggests that gabapentin, a relatively common anti-seizure/pain medication, is linked to improved survival in patients with glioblastoma (GBM) — the most common and deadly form of brain cancer in adults. The findings, published in Nature Communications, are based on a retrospective analysis and add new evidence to help patients with this devastating disease.
“This study is an exciting step forward,” said lead author Joshua Bernstock,…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply